Xuan Shen

Scrophularia ningpoensis Hemsl.

Also known as: Figwort root(English) 玄参(Chinese)

Genjin玄参 ゲンジン(JP also admits Scrophularia buergeriana) Hyeonsam玄參 현삼 Hsüan Shên

Updated October 23, 2026 · Not yet clinically reviewed

Safety at a glance

High risk

Do not combine with Li Lu (十八反)

Caution

5 recorded drug interactions, 1 major or contraindicated

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
clearing heat
Temperature
Cool
Taste
Sweet,Bitter,Salty
Channels
Lung,Stomach,Kidney

Functions

Clears Heat and Cools the Blood; Nourishes Yin and Generates Fluids; Purges Fire and Resolves Toxicity; Dissipates Nodules and Softens Hardness

Traditional uses

Xuan Shen (figwort root, scrophularia) is a cool, salty herb that both nourishes Yin and clears Fire — making it one of the few herbs that addresses the combined pattern of Yin deficiency with fire flaring. It is used for sore throat, swollen glands, and neck nodules from Heat toxin or Phlegm-Fire, as well as for the bone-steaming heat and constipation of Yin deficiency with internal heat. Its salty softening action makes it useful for hard lumps and accumulations, including thyroid and lymph node swellings.

Western herbalism

Pharmacological effects

  • Hypotensive: Aqueous/ethanolic extracts and decoction lowered blood pressure in anesthetized dogs, cats and rabbits; oral 2 g/kg twice daily more hypotensive in renal-hypertensive than normal dogs; 5-10% extract vasodilated toad hindlimb vessels.
  • Central inhibitory: S.c. or i.p. aqueous extract 2.5-6 g/kg reduced spontaneous activity and prolonged cyclobarbital sleep in mice.
  • Other effects: S.c. extract 5 g/kg slightly lowered blood glucose; antipyretic and antifungal activities reported.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 161.

Formulas using this herb

51 of 51 formulas

Botanical

Scrophularia ningpoensis is a tall herbaceous perennial in the Scrophulariaceae, native to central and eastern China, where it grows in moist, shaded sites along forest margins, stream banks and grassy slopes between 800 and 2,400 m elevation. Plants reach 60-150 cm tall from a cluster of thick, fleshy, spindle-shaped roots that are pale grey-brown outside and turn black on drying. The erect, four-angled stems are usually unbranched below and bear opposite, ovate to elliptic-lanceolate leaves 7-20 cm long, with serrate margins, pointed tips and short petioles. In summer to early autumn the species produces narrow, open, terminal panicles of small dingy yellow-green to dull purple flowers, each tubular with a two-lipped limb about 8 mm long. The fruits are ovoid capsules containing many small, angular seeds. The species is cultivated in Zhejiang Province, where the roots are lifted in late autumn and steamed or sweated before drying.

Family
Scrophulariaceae
Pharmaceutical name
Radix Scrophulariae
Parts used
root
Plant type
herb
Native region
Hubei, Sichuan, Zhejiang

Constituents

Harpagoside

Iridoid glycoside · 0.24 plus or minus 0.04 percent of the dried root in first-grade material, 0.21 plus or minus 0.04 percent in second grade and 0.11 plus or minus 0.03 percent in third grade

One of the two iridoid markers used for Scrophulariae Radix in the 2020 Chinese Pharmacopoeia, and the compound most often used to justify the drug. Its documented activity is neuroprotective rather than anti-inflammatory: in rotenone-injured Neuro-2A cells it improved survival, suppressed nitric oxide generation and reduced alpha-synuclein nitration through NF-kappaB/NOS signalling, and protected mitochondrial complex I activity. In human neutrophils it showed no significant anti-inflammatory effect, which is an awkward result for a heat-clearing herb standardised on it.

Harpagide

Iridoid glycoside · quantified alongside harpagoside as the paired Chinese Pharmacopoeia (2020) marker for Scrophulariae Radix

Co-marker with harpagoside. It alleviated sepsis-induced acute respiratory distress in mice by reshaping the gut microbiota toward acetate production, acting through the FFAR2 receptor; the effect disappeared under antibiotic depletion and in Ffar2 knockouts. Like harpagoside, it showed no significant direct anti-inflammatory effect in the neutrophil ROS assay.

Angoroside C

Phenylpropanoid (cinnamic acid) glycoside · the most abundant cinnamic acid glycoside of the root; quantified routinely alongside cinnamic acid and harpagoside

The strongest candidate for the herb's actual heat-clearing activity. It inhibited fMLF-induced total ROS generation by activated human neutrophils with an IC50 of 0.34 micromolar, and the chemometric study that measured this proposed it as a better chemical marker for the herb than the currently regulated iridoids.

Acteoside (verbascoside) and isoacteoside

Phenylethanoid glycoside

The most potent anti-inflammatory compounds identified in the root: IC50 0.04 to 0.12 micromolar against fMLF-stimulated ROS generation in human neutrophils, roughly an order of magnitude more potent than angoroside C and far more potent than the iridoid markers. Their activity in that assay was attributed to oxygen radical scavenging.

Cinnamic acid

Phenylpropanoid (aromatic carboxylic acid) · 0.08 plus or minus 0.01 percent of the dried root in first-grade material, falling to 0.03 plus or minus 0.006 percent in third grade

Declines in step with harpagoside across commercial grades, which makes the two useful together as a grading signal. It is one of the four components followed in rat pharmacokinetic work on the herb.

Acetylharpagide

Iridoid glycoside

Reported from Scrophularia ningpoensis and cytoprotective alongside harpagoside in rotenone-treated Neuro-2A cells. Not a pharmacopoeial marker and not routinely quantified in commercial material.

Drug interactions

Li Lu (Veratrum nigrum and other Veratrum species)

Major · Classical absolute prohibition; the risk carried is Veratrum's own steroidal alkaloid toxicity, which is cardiotoxic and can be fatal · Evidence level: Theoretical

Xuan Shen is one of the shen herbs named in the Eighteen Incompatibilities (shi ba fan), whose verse places all the shen, plus Xi Xin and Shao Yao, in opposition to Li Lu; the prohibition for Xuan Shen specifically is set out in the Ben Cao Gang Mu. The hazard is real independently of the classical rule. Veratrum nigrum contains steroidal alkaloids of the jervine and veratrum-ester types with a narrow margin between emetic and cardiotoxic doses, producing bradycardia, hypotension and arrhythmia, and its toxicity and incompatibility are the subject of a dedicated 2024 review. Experimental work on the incompatibility pairs has been done for Veratrum with ginseng and with asarum rather than with Scrophularia, so no mechanism specific to this pair has been demonstrated; the interaction is classified Theoretical on that ground, not because the risk is small.

Clinical note: Do not combine. Li Lu is rarely dispensed in modern practice, but check patent and imported formulas, which is where it turns up unannounced. If a patient has taken the combination, the assessment to make is Veratrum poisoning, not a herb-herb reaction: check pulse, blood pressure and ECG.

Scrophularia buergeriana, S. kakudensis and S. yoshimurae supplied as Radix Scrophulariae

Moderate · Marker content and therefore effective dose differ substantially between species; a nominal gram dose does not transfer · Evidence level: Established

These three congeners are documented adulterants of Scrophulariae Radix, and a 2025 RAD-seq study was undertaken specifically because conventional identification could not reliably separate them from S. ningpoensis. The substitution is not cosmetic: harpagoside content in HPLC-MS analysis was 1.94 plus or minus 0.24 mg/g in S. buergeriana against 6.47 plus or minus 0.02 mg/g in S. koraiensis and 5.50 plus or minus 0.02 mg/g in S. takesimensis, a more than threefold spread across Scrophularia species. S. buergeriana is also an accepted botanical source of Scrophulariae Radix in Korean practice, so the same Latin drug name can lawfully mean a different plant depending on where the material was bought.

Clinical note: Specify Scrophularia ningpoensis by binomial when ordering, and treat Korean-sourced Scrophulariae Radix as potentially S. buergeriana. Where dosing is being titrated to effect, do not carry the dose across a change of supplier.

Digoxin and other cardiac glycosides

Theoretical · No interaction is expected with this species; the caution in circulation belongs to a different plant · Evidence level: Theoretical

Recorded to stop a species confusion propagating. Western herbal sources carry a cardiac glycoside caution for figwort, which refers to Scrophularia nodosa. Scrophularia ningpoensis is a different species, and the two comprehensive reviews of it catalogue more than 162 compounds across iridoids and iridoid glycosides, phenylpropanoid glycosides, organic acids, volatile oils, terpenoids, saccharides, flavonoids, sterols and saponins, with no cardenolides among them. The reviews do describe cardiovascular activity, including an anti-ventricular-remodelling effect, but that is not glycoside pharmacology.

Clinical note: Do not apply a Scrophularia nodosa monograph to this herb. No digoxin level monitoring is indicated on the strength of Xuan Shen alone.

Insulin, sulfonylureas and other glucose-lowering drugs

Theoretical · Possible additive glucose lowering · Evidence level: Theoretical

Scrophulariae Radix is used clinically in China for diabetes, and its anti-inflammatory, antioxidative and immunomodulatory constituents are reviewed for that indication. The supporting work is preclinical and review-level; no human pharmacodynamic study of the herb with a glucose-lowering drug was found, and no magnitude of effect can be given.

Clinical note: In a patient on insulin or a sulfonylurea, ask them to monitor capillary glucose more closely for the first two weeks of a Xuan Shen containing formula. No dose change should be made pre-emptively.

Levothyroxine and antithyroid drugs (carbimazole, methimazole, propylthiouracil)

Theoretical · Unquantified; the herb is used in patterns overlapping thyroid disease, so concurrent use is common · Evidence level: Theoretical

Scrophulariae Radix is a standard component of Chinese formulas for goitre and thyroid disorders and is reviewed specifically for its mechanisms in thyroid disease. No pharmacokinetic or pharmacodynamic study of the herb with levothyroxine or an antithyroid drug was located, so the direction and size of any effect are unknown.

Clinical note: If the herb is started or stopped in a patient on thyroid replacement or suppression, bring forward the next thyroid function test rather than assuming stability.

Dosage

FormAmountFrequencyNotes
decoction9–15 gDaily
中国药典 2020 【用法与用量】9~15g。 【注意】不宜与藜芦同用。 【性味与归经】甘、苦、咸,微寒。归肺、胃、肾经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Dui yao: classical pairings

Xuan Shen + Cang Zhu苍术

The moistening, yin-nourishing herb restrains the drying herb while the drying herb strengthens the spleen, a balanced pair Shi Jinmo used for wasting-thirst.

Named pairing — Lü Jingshan, Shi Jinmo Dui Yao

Xuan Shen + Mai Men Dong麦门冬

Clearing heat and nourishing yin is combined with moistening the lung and stomach, together increasing fluids to moisten dryness.

Core pair of a classical formula — Zeng Ye Tang, Wen Bing Tiao Bian (Wu Jutong)

Xuan Shen + Sheng Di Huang生地黄

Cooling the blood and nourishing yin are combined with generating fluids, moistening dryness caused by heat damaging yin.

Constipation from depleted fluids in warm disease, dry mouth.

Core pair of a classical formula — Zeng Ye Tang, Wen Bing Tiao Bian (Wu Jutong)

Xuan Shen + Zhe Bei Mu浙贝母

Clears heat, transforms phlegm and dissipates nodules while cooling and nourishing yin to soften hardness.

Scrofula and phlegm nodules from yin deficiency with phlegm-fire.

Core pair of a classical formula — Xiao Luo Wan, Yi Xue Xin Wu (Cheng Guopeng, 1732)

Evidence

Study design on record, not certainty of outcome.

In vitro / animal
4

Chemometric-guided chemical marker selection: A case study of the heat-clearing herb Scrophularia ningpoensis

Wang LS, Chen PJ, Cheng WC, Chang YC, El-Shazly M, Chen LY, Peng BR, Su CH, Yen PT, Hwang TL, Lai KH · Frontiers in Plant Science · 2023 · in vitro

In vitro / animal · Not yet verified

Built an anti-inflammatory metabolomic pattern for the root using multi-informative molecular networking, then validated it against ROS generation by activated human neutrophils. Cinnamic acid glycosides scored highest: all compounds from the bioactive molecular families inhibited fMLF-promoted total ROS dose-dependently with IC50 values of 0.04 to 0.42 micromolar (acteoside and isoacteoside 0.04 to 0.12 micromolar, angoroside C 0.34 micromolar), while compounds from the non-bioactive clusters, which include the regulated iridoids harpagide and harpagoside, showed no significant effect. The authors propose angoroside C rather than the iridoids as the chemical marker for this species.

doi:10.3389/fpls.2023.1153710

Reduced levels of nitrated α-synuclein in the protective effect of harpagoside on rotenone-induced cellular models of Parkinson’s disease

Lang J, Xiong Z · Frontiers in Cell and Developmental Biology · 2025 · in vitro

In vitro / animal · Not yet verified

Three iridoids from Scrophularia ningpoensis, harpagoside, acetylharpagide and harpagide, were tested against rotenone injury in Neuro-2A neuronal and BV-2 microglial cells, with catalpol as reference. Acetylharpagide and harpagoside were substantially cytoprotective. Harpagoside suppressed nitric oxide generation and inhibited alpha-synuclein nitration, with pathway analysis implicating NF-kappaB/NOS/NO signalling.

doi:10.3389/fcell.2025.1624315

Protective effects of harpagoside on mitochondrial functions in rotenone‑induced cell models of Parkinson's disease

Lang J, Xiong Z · Biomedical Reports · 2025 · in vitro

In vitro / animal · Not yet verified

Harpagoside in rotenone-treated differentiated Neuro-2A cells. At 10 micromolar it raised cell survival; from 0.1 micromolar it reduced mitochondrial swelling; at 1 micromolar it countered rotenone inhibition of complex I; and at 10 micromolar it inhibited caspase 3 activation. Note that the authors describe harpagoside as obtainable from Scrophularia buergeriana, S. striata and Harpagophytum procumbens as well, so the finding is about the compound, not uniquely about this species.

doi:10.3892/br.2025.1942

Determination and Pharmacokinetic Profiles of Four Active Components From Scrophularia ningpoensis Hemsl. in Rats

Luo S, Xie L, Chen J, Tang C, Xu RA · Frontiers in Pharmacology · 2021 · animal

In vitro / animal · Not yet verified

Determined and compared the pharmacokinetic profiles of four active components of Scrophularia ningpoensis in rats, establishing that the marker compounds show distinct absorption and metabolic behaviour rather than moving together. This matters for dosing logic: standardising on one iridoid does not predict systemic exposure to the phenylpropanoid glycosides that carry most of the in vitro anti-inflammatory potency.

doi:10.3389/fphar.2020.612534

Safety

Contraindications

It is not suitable for patients with less eating and thin, unformed stool due to deficiency-cold of the spleen and stomach. It antagonizes Radix et Rhizoma Veratri Nigri ( li lu ).

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 81–84.

⚠ Rule-based cautions

These entries come from the deterministic rule tables that gate Verscienta's formula tools: classical pair prohibitions, pregnancy and lactation contraindications, dose ceilings, and drugs outside the Chinese Pharmacopoeia. The botanical-genus entries are different: advisory notes are not part of the safety screen; the Aristolochia genus check is.

Incompatibilities (十八反 / 十九畏)

  • 十八反: Li Lu × Xuan Shen — avoid combining with Li Lu / Veratrum

Cultural and historical

Shen Nong Ben Cao Jing · Han dynasty

Xuan Shen is entered among the middle-grade drugs, establishing it as one of the earliest recorded members of the materia medica; the drug has been in continuous use in East Asia for over two thousand years.

Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen · Ming dynasty, 1596

Sets out the prohibition on combining Xuan Shen with Li Lu (Veratrum), placing it among the shen herbs of the Eighteen Incompatibilities. This is the classical source usually cited for the Xuan Shen and Li Lu pair specifically.

Ben Cao Jing Ji Zhu (Collected Commentaries on the Classic of Materia Medica), Tao Hongjing · Southern and Northern dynasties, circa 500 CE

Tao Hongjing's commentary tradition is where the seven relations of herb combination, including mutual antagonism and incompatibility, are systematised; it is the framework the later Eighteen Incompatibilities verse formalises.

References

  1. Zhang Q, Liu A, Wang Y. Scrophularia ningpoensis Hemsl: a review of its phytochemistry, pharmacology, quality control and pharmacokinetics. Journal of Pharmacy and Pharmacology. 2021 doi:10.1093/jpp/rgaa036
  2. Ren D, Shen ZY, Qin LP, Zhu B. Pharmacology, phytochemistry, and traditional uses of Scrophularia ningpoensis Hemsl. Journal of Ethnopharmacology. 2021 doi:10.1016/j.jep.2020.113688
  3. Lu YA, Liu SJ, Hou SY, Ge YY, Xia BH, Xie MX. Metabolomics distinguishes different grades of Scrophularia ningpoensis hemsl: Towards a biomarker discovery and quality evaluation. Heliyon. 2024 doi:10.1016/j.heliyon.2024.e28458
  4. Zhang M, Chen K, Feng C, Zhang F, Zhang L, Li Y. The Comprehensive Profiling of the Chemical Components in the Raw and Processed Roots of Scrophularia ningpoensis by Combining UPLC-Q-TOF-MS Coupled with MS/MS-Based Molecular Networking. Molecules. 2024 doi:10.3390/molecules29204866
  5. Guo L, Wang X, Li H, Zhou M, Liu L, Wang R, Li P. Using RAD-seq to identify and differentiate the medicinal herb Scrophularia ningpoensis and its adulterants. BMC Genomics. 2025 doi:10.1186/s12864-025-11304-7
  6. Nam HH, Lee AY, Seo YS, Park I, Yang S, Chun JM, Moon BC, Song JH, Kim JS. Three Scrophularia Species (Scrophularia buergeriana, S. koraiensis, and S. takesimensis) Inhibit RANKL-Induced Osteoclast Differentiation in Bone Marrow-Derived Macrophages. Plants. 2020 doi:10.3390/plants9121656
  7. Song J, Li J, Shi H, Liu H, Qu Y, Wang F. The mechanism and application of Scrophulariae Radix in the treatment of endocrine disorders: focusing on thyroid diseases and diabetes mellitus. Frontiers in Endocrinology. 2025 doi:10.3389/fendo.2025.1684744
  8. Zhao X, Li S, Xiang Z. Veratrum nigrum L.: A comprehensive review of ethnopharmacology, phytochemistry, pharmacology, pharmacokinetics and metabolism, toxicity, and incompatibility. Journal of Ethnopharmacology. 2024 doi:10.1016/j.jep.2024.118219
  9. Su L, Deng Y, Chen N, Zhang X, Huang T. Infrared-assisted extraction followed by high performance liquid chromatography to determine angoroside C, cinnamic acid, and harpagoside content in Scrophularia ningpoensis. BMC Complementary and Alternative Medicine. 2019 doi:10.1186/s12906-019-2552-2

Look-alike names

© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice